| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | SPG7 DNAH10 DNAH17 AACS MYO18A SMARCA2 SMARCA4 SRP54 RFC1 YME1L1 ABCA10 ATP4A | 3.40e-07 | 614 | 62 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | SPG7 DNAH10 RRAGA MYO18A SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 ATP4A ARF6 | 3.89e-06 | 775 | 62 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 8.29e-06 | 441 | 62 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | SPG7 DNAH10 RRAGA MYO18A SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 ATP4A ARF6 | 8.71e-06 | 839 | 62 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | SPG7 DNAH10 RRAGA MYO18A SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 ATP4A ARF6 | 8.82e-06 | 840 | 62 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | SPG7 DNAH10 RRAGA MYO18A SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 ATP4A ARF6 | 8.82e-06 | 840 | 62 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 8.04e-05 | 231 | 62 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | ATP-dependent peptidase activity | 2.62e-04 | 8 | 62 | 2 | GO:0004176 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 4.74e-04 | 49 | 62 | 3 | GO:0005547 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.55e-04 | 127 | 62 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 9.60e-04 | 507 | 62 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 9.60e-04 | 507 | 62 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.41e-03 | 18 | 62 | 2 | GO:0008569 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell polarity | 1.50e-07 | 42 | 61 | 5 | GO:0090162 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 5.88e-07 | 23 | 61 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 7.04e-07 | 24 | 61 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum-Golgi intermediate compartment organization | 8.60e-06 | 2 | 61 | 2 | GO:0097111 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.38e-05 | 177 | 61 | 6 | GO:0030010 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.45e-05 | 531 | 61 | 9 | GO:0042692 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D9B HDAC6 SWAP70 BST1 VPS13C SMARCA2 SMARCA4 LMOD1 AKAP13 SYT2 SNCA YME1L1 HNRNPU ARF6 | 2.84e-05 | 1342 | 61 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 5.54e-05 | 333 | 61 | 7 | GO:0051056 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CFLAR NRAP HDAC6 SWAP70 BST1 CYTH2 MYO18A LMOD1 AKAP13 PARD3 ARF6 | 6.54e-05 | 912 | 61 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | cellular component disassembly | 7.83e-05 | 617 | 61 | 9 | GO:0022411 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 9.26e-05 | 80 | 61 | 4 | GO:1903409 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 1.10e-04 | 257 | 61 | 6 | GO:0007163 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 1.13e-04 | 803 | 61 | 10 | GO:0030036 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.23e-04 | 86 | 61 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 1.28e-04 | 6 | 61 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.40e-04 | 89 | 61 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 1.51e-04 | 391 | 61 | 7 | GO:0051146 | |
| GeneOntologyBiologicalProcess | type 2 mitophagy | 1.79e-04 | 7 | 61 | 2 | GO:0061734 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 2.17e-04 | 291 | 61 | 6 | GO:0072593 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 2.18e-04 | 185 | 61 | 5 | GO:0031960 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 2.92e-04 | 579 | 61 | 8 | GO:0051493 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 3.39e-04 | 112 | 61 | 4 | GO:0010507 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 3.41e-04 | 46 | 61 | 3 | GO:0009303 | |
| GeneOntologyBiologicalProcess | Golgi vesicle budding | 3.81e-04 | 10 | 61 | 2 | GO:0048194 | |
| GeneOntologyBiologicalProcess | organelle assembly | CFLAR TBC1D9B GBF1 NRAP HDAC6 DNAH17 TTC12 LMOD1 AKAP13 STX17 HNRNPU | 4.51e-04 | 1138 | 61 | 11 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of dendrite development | 5.57e-04 | 12 | 61 | 2 | GO:2000171 | |
| GeneOntologyBiologicalProcess | response to dexamethasone | 5.79e-04 | 55 | 61 | 3 | GO:0071548 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.03e-04 | 239 | 61 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 7.03e-04 | 239 | 61 | 5 | GO:0031032 | |
| GeneOntologyBiologicalProcess | cellular response to nerve growth factor stimulus | 7.11e-04 | 59 | 61 | 3 | GO:1990090 | |
| GeneOntologyCellularComponent | Gtr1-Gtr2 GTPase complex | 5.34e-05 | 4 | 63 | 2 | GO:1990131 | |
| GeneOntologyCellularComponent | bBAF complex | 3.96e-04 | 10 | 63 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | bicellular tight junction | 6.59e-04 | 131 | 63 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | cytoplasmic region | 7.44e-04 | 360 | 63 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | npBAF complex | 7.95e-04 | 14 | 63 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 7.95e-04 | 14 | 63 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | tight junction | 8.23e-04 | 139 | 63 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | nBAF complex | 1.04e-03 | 16 | 63 | 2 | GO:0071565 | |
| HumanPheno | Abnormality of peripheral nervous system electrophysiology | 4.23e-05 | 315 | 23 | 8 | HP:0030177 | |
| HumanPheno | Abnormal peripheral nervous system physiology | 4.63e-05 | 319 | 23 | 8 | HP:0032120 | |
| Domain | - | 1.37e-07 | 15 | 61 | 4 | 1.10.1000.11 | |
| Domain | Sec7 | 1.37e-07 | 15 | 61 | 4 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.37e-07 | 15 | 61 | 4 | IPR023394 | |
| Domain | Sec7 | 1.82e-07 | 16 | 61 | 4 | SM00222 | |
| Domain | SEC7 | 1.82e-07 | 16 | 61 | 4 | PS50190 | |
| Domain | Sec7_dom | 1.82e-07 | 16 | 61 | 4 | IPR000904 | |
| Domain | - | SPG7 DNAH10 RRAGA MYO18A SMARCA2 SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 HNRNPU ARF6 | 6.62e-07 | 746 | 61 | 13 | 3.40.50.300 |
| Domain | P-loop_NTPase | SPG7 DNAH10 RRAGA MYO18A SMARCA2 SMARCA4 SRP54 RRAGB RFC1 YME1L1 ABCA10 HNRNPU ARF6 | 2.76e-06 | 848 | 61 | 13 | IPR027417 |
| Domain | AAA+_ATPase | 7.41e-06 | 144 | 61 | 6 | IPR003593 | |
| Domain | AAA | 7.41e-06 | 144 | 61 | 6 | SM00382 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 1.05e-05 | 2 | 61 | 2 | IPR014978 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | IPR029295 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | PF14619 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | SM00951 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PS51666 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PF08880 | |
| Domain | FtsH | 3.14e-05 | 3 | 61 | 2 | IPR005936 | |
| Domain | Peptidase_M41 | 3.14e-05 | 3 | 61 | 2 | IPR000642 | |
| Domain | Peptidase_M41 | 3.14e-05 | 3 | 61 | 2 | PF01434 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | SM00573 | |
| Domain | Gtr1_RagA | 6.27e-05 | 4 | 61 | 2 | PF04670 | |
| Domain | Gtr1_RagA | 6.27e-05 | 4 | 61 | 2 | IPR006762 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PS51204 | |
| Domain | HSA_dom | 6.27e-05 | 4 | 61 | 2 | IPR014012 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PF07529 | |
| Domain | BRK | 1.56e-04 | 6 | 61 | 2 | SM00592 | |
| Domain | BRK_domain | 1.56e-04 | 6 | 61 | 2 | IPR006576 | |
| Domain | BRK | 1.56e-04 | 6 | 61 | 2 | PF07533 | |
| Domain | PH | 2.88e-04 | 278 | 61 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.94e-04 | 279 | 61 | 6 | PS50003 | |
| Domain | PH_domain | 2.99e-04 | 280 | 61 | 6 | IPR001849 | |
| Domain | AAA | 6.54e-04 | 52 | 61 | 3 | PF00004 | |
| Domain | ATPase_AAA_core | 7.30e-04 | 54 | 61 | 3 | IPR003959 | |
| Domain | PH | 9.03e-04 | 229 | 61 | 5 | PF00169 | |
| Domain | - | 1.70e-03 | 391 | 61 | 6 | 2.30.29.30 | |
| Domain | - | 2.12e-03 | 21 | 61 | 2 | 1.10.720.30 | |
| Domain | SAP | 2.32e-03 | 22 | 61 | 2 | PF02037 | |
| Domain | SAP | 2.54e-03 | 23 | 61 | 2 | SM00513 | |
| Domain | PH_dom-like | 2.62e-03 | 426 | 61 | 6 | IPR011993 | |
| Domain | SAP | 3.00e-03 | 25 | 61 | 2 | PS50800 | |
| Domain | SAP_dom | 3.00e-03 | 25 | 61 | 2 | IPR003034 | |
| Domain | Bromodomain_CS | 3.24e-03 | 26 | 61 | 2 | IPR018359 | |
| Domain | SNF2_N | 4.89e-03 | 32 | 61 | 2 | IPR000330 | |
| Domain | SNF2_N | 4.89e-03 | 32 | 61 | 2 | PF00176 | |
| Domain | BROMODOMAIN_1 | 6.49e-03 | 37 | 61 | 2 | PS00633 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 7.36e-08 | 12 | 51 | 4 | MM1342 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 3.49e-07 | 17 | 51 | 4 | M2482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 1.82e-06 | 25 | 51 | 4 | M47716 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.38e-06 | 29 | 51 | 4 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.88e-06 | 30 | 51 | 4 | M47738 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.31e-05 | 145 | 51 | 6 | M45512 | |
| Pathway | PID_PI3KCI_PATHWAY | 2.63e-05 | 48 | 51 | 4 | M141 | |
| Pathway | PID_ARF6_PATHWAY | 2.69e-04 | 35 | 51 | 3 | M86 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 3.18e-04 | 37 | 51 | 3 | MM15354 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 5.32e-04 | 44 | 51 | 3 | M27652 | |
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 1.00e-12 | 8 | 64 | 5 | 20080746 | |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 2.05e-10 | 19 | 64 | 5 | 30674481 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HDAC6 POLR1A ACLY SMARCA2 SMARCA4 CCAR1 SRP54 AKAP13 MACROH2A2 TANC1 RBM28 CDC5L RFC1 PARD3 YME1L1 AARSD1 HNRNPU | 2.37e-10 | 1353 | 64 | 17 | 29467282 |
| Pubmed | 7.26e-10 | 8 | 64 | 4 | 17398095 | ||
| Pubmed | 1.30e-09 | 9 | 64 | 4 | 17846866 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 18042453 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 23095975 | ||
| Pubmed | Complex regulation of multiple cytohesin-like genes in murine tissues and cells. | 5.94e-09 | 3 | 64 | 3 | 9744817 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POLR1A VPS13C ANKAR TTC12 AFF3 SMARCA2 CCAR1 SRP54 SRPK2 AKAP13 MACROH2A2 TANC1 SYT2 PARD3 STX17 HNRNPU | 8.22e-09 | 1489 | 64 | 16 | 28611215 |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10652308 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 12606567 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 12920129 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MICALL1 GBF1 POLR1A SWAP70 ACLY MYO18A CCAR1 SRP54 AKAP13 HMMR MXRA7 | 8.05e-08 | 724 | 64 | 11 | 36232890 |
| Pubmed | INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling. | 1.18e-07 | 6 | 64 | 3 | 30355448 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1A MYO18A SMARCA4 SRPK2 MACROH2A2 HMMR RBM28 CDC5L RFC1 YME1L1 HNRNPU | 1.29e-07 | 759 | 64 | 11 | 35915203 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MICALL1 GBF1 HDAC6 ACLY MYO18A SMARCA2 SMARCA4 CCAR1 RFC1 PARD3 OTUD7B | 1.57e-07 | 774 | 64 | 11 | 15302935 |
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 1.77e-07 | 27 | 64 | 4 | 29420262 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 18084281 | ||
| Pubmed | 1.22e-06 | 43 | 64 | 4 | 26030138 | ||
| Pubmed | MICALL1 MYO18A SRP54 SRPK2 AKAP13 TANC1 HMMR RBM28 CDC5L PLCH1 PARD3 YME1L1 MXRA7 | 2.60e-06 | 1487 | 64 | 13 | 33957083 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8670841 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 3.33e-06 | 2 | 64 | 2 | 23076393 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 3.33e-06 | 2 | 64 | 2 | 9603422 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15576411 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23276717 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27097303 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15240517 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26564006 | ||
| Pubmed | Structural Dynamics Control Allosteric Activation of Cytohesin Family Arf GTPase Exchange Factors. | 3.33e-06 | 2 | 64 | 2 | 29276036 | |
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 3.33e-06 | 2 | 64 | 2 | 33027072 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28038711 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23872584 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21235576 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 3.33e-06 | 2 | 64 | 2 | 23963727 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 3.33e-06 | 2 | 64 | 2 | 31375262 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 3.33e-06 | 2 | 64 | 2 | 23088494 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 30943106 | ||
| Pubmed | Genome-wide association study confirms extant PD risk loci among the Dutch. | 3.33e-06 | 2 | 64 | 2 | 21248740 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17075831 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25736891 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20333683 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34812766 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 3.33e-06 | 2 | 64 | 2 | 32855269 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 3.33e-06 | 2 | 64 | 2 | 30478150 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23517829 | ||
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 3.33e-06 | 2 | 64 | 2 | 22721696 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18508913 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11719516 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34390832 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20018626 | ||
| Pubmed | Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. | 3.33e-06 | 2 | 64 | 2 | 9050849 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 3.33e-06 | 2 | 64 | 2 | 25808524 | |
| Pubmed | Analysis of genome-wide association study-linked loci in Parkinson's disease of Mainland China. | 3.33e-06 | 2 | 64 | 2 | 23853107 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 3.33e-06 | 2 | 64 | 2 | 19144648 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16484220 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38419457 | ||
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 3.33e-06 | 2 | 64 | 2 | 28706277 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21092585 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 3.33e-06 | 2 | 64 | 2 | 29391527 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31601460 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37634210 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26551623 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19458193 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8208605 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34289068 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34518526 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32312722 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28499252 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26356327 | ||
| Pubmed | Phospho-HDAC6 Gathers Into Protein Aggregates in Parkinson's Disease and Atypical Parkinsonisms. | 3.33e-06 | 2 | 64 | 2 | 32655357 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12566296 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 3.33e-06 | 2 | 64 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 3.33e-06 | 2 | 64 | 2 | 12620226 | |
| Pubmed | RagA is a functional homologue of S. cerevisiae Gtr1p involved in the Ran/Gsp1-GTPase pathway. | 3.33e-06 | 2 | 64 | 2 | 9394008 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31406271 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27039070 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29848589 | ||
| Pubmed | Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits. | 3.33e-06 | 2 | 64 | 2 | 29273066 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 7499430 | ||
| Pubmed | Cytohesin 2/ARF6 regulates preadipocyte migration through the activation of ERK1/2. | 3.33e-06 | 2 | 64 | 2 | 25450674 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24866403 | ||
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 3.42e-06 | 124 | 64 | 5 | 22944692 | |
| Pubmed | 4.71e-06 | 234 | 64 | 6 | 36243803 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GBF1 HDAC6 SWAP70 MYO18A SMARCA2 CCAR1 SRP54 HMMR RFC1 AARSD1 MXRA7 HNRNPU | 6.41e-06 | 1367 | 64 | 12 | 32687490 |
| Pubmed | 6.87e-06 | 250 | 64 | 6 | 33536335 | ||
| Pubmed | 7.65e-06 | 733 | 64 | 9 | 34672954 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31022698 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28292935 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 36464671 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22162999 | ||
| Pubmed | DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1. | 9.99e-06 | 3 | 64 | 2 | 30287812 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20525696 | ||
| Pubmed | Metabolism. Differential regulation of mTORC1 by leucine and glutamine. | 9.99e-06 | 3 | 64 | 2 | 25567907 | |
| Pubmed | Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation. | 9.99e-06 | 3 | 64 | 2 | 38092135 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 24581425 | ||
| Pubmed | ARF6 activation by Galpha q signaling: Galpha q forms molecular complexes with ARNO and ARF6. | 9.99e-06 | 3 | 64 | 2 | 16650966 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22659138 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28780751 | ||
| Interaction | ACTB interactions | CYBB NRAP HDAC6 SWAP70 RRAGA ACLY MYO18A SMARCA2 SMARCA4 LMOD1 SRPK2 TANC1 HMMR CDC5L SNCA HNRNPU | 1.45e-07 | 1083 | 63 | 16 | int:ACTB |
| Interaction | GNAQ interactions | 2.10e-07 | 135 | 63 | 7 | int:GNAQ | |
| Interaction | HSP90B1 interactions | HDAC6 POLR1A SWAP70 DNAH10 ACLY VPS13C DNAH17 SMARCA4 AKAP13 CDC5L PLCH1 HNRNPU | 6.78e-07 | 650 | 63 | 12 | int:HSP90B1 |
| Interaction | MYBBP1A interactions | HDAC6 POLR1A SMARCA2 SMARCA4 SRPK2 MACROH2A2 RBM28 CDC5L SNCA HNRNPU | 1.60e-06 | 463 | 63 | 10 | int:MYBBP1A |
| Interaction | IPCEF1 interactions | 4.72e-06 | 11 | 63 | 3 | int:IPCEF1 | |
| Interaction | SEPTIN7 interactions | 6.99e-06 | 228 | 63 | 7 | int:SEPTIN7 | |
| Interaction | HECTD1 interactions | POLR1A GPATCH1 MYO18A SMARCA4 SRPK2 MACROH2A2 HMMR RBM28 CDC5L RFC1 YME1L1 AARSD1 HNRNPU | 8.92e-06 | 984 | 63 | 13 | int:HECTD1 |
| Interaction | CTNND1 interactions | 1.85e-05 | 265 | 63 | 7 | int:CTNND1 | |
| Interaction | CYTIP interactions | 1.92e-05 | 17 | 63 | 3 | int:CYTIP | |
| Interaction | CYTH1 interactions | 2.62e-05 | 55 | 63 | 4 | int:CYTH1 | |
| Interaction | SNRPB interactions | 3.10e-05 | 517 | 63 | 9 | int:SNRPB | |
| Interaction | SEPTIN11 interactions | 3.97e-05 | 122 | 63 | 5 | int:SEPTIN11 | |
| Interaction | SNIP1 interactions | 4.50e-05 | 417 | 63 | 8 | int:SNIP1 | |
| Interaction | TOP1 interactions | HDAC6 SMARCA4 CCAR1 SRPK2 MACROH2A2 RBM28 CDC5L RFC1 SNCA HNRNPU | 5.53e-05 | 696 | 63 | 10 | int:TOP1 |
| Interaction | ARHGAP21 interactions | 6.89e-05 | 223 | 63 | 6 | int:ARHGAP21 | |
| Interaction | LYN interactions | MICALL1 HDAC6 POLR1A CCAR1 TANC1 RBM28 SNCA PLCH1 PARD3 ARF6 | 7.34e-05 | 720 | 63 | 10 | int:LYN |
| Interaction | ARRB2 interactions | 8.16e-05 | 454 | 63 | 8 | int:ARRB2 | |
| Interaction | CTNNA1 interactions | 1.02e-04 | 347 | 63 | 7 | int:CTNNA1 | |
| Interaction | YWHAE interactions | MICALL1 GBF1 NRAP HDAC6 ACLY CYTH2 AKAP13 TANC1 CDC5L SNCA PLCH1 PARD3 HNRNPU | 1.13e-04 | 1256 | 63 | 13 | int:YWHAE |
| Interaction | EED interactions | TBC1D9B ACLY VPS13C MYO18A SMARCA2 SMARCA4 CCAR1 SRPK2 MACROH2A2 TANC1 RBM28 CDC5L HNRNPU ARF6 | 1.19e-04 | 1445 | 63 | 14 | int:EED |
| Interaction | KHDRBS1 interactions | 1.60e-04 | 373 | 63 | 7 | int:KHDRBS1 | |
| Interaction | SH3GL1 interactions | 1.61e-04 | 164 | 63 | 5 | int:SH3GL1 | |
| Interaction | CCDC40 interactions | 1.63e-04 | 34 | 63 | 3 | int:CCDC40 | |
| Interaction | CALD1 interactions | 1.77e-04 | 265 | 63 | 6 | int:CALD1 | |
| Interaction | EPS8L3 interactions | 2.00e-04 | 7 | 63 | 2 | int:EPS8L3 | |
| Interaction | KPNA2 interactions | 2.05e-04 | 519 | 63 | 8 | int:KPNA2 | |
| Interaction | TOP2A interactions | 2.07e-04 | 520 | 63 | 8 | int:TOP2A | |
| Interaction | RB1 interactions | 2.23e-04 | 394 | 63 | 7 | int:RB1 | |
| Interaction | TRAF3 interactions | 2.29e-04 | 278 | 63 | 6 | int:TRAF3 | |
| Interaction | LMO7 interactions | 2.30e-04 | 177 | 63 | 5 | int:LMO7 | |
| Interaction | CDH13 interactions | 2.65e-04 | 40 | 63 | 3 | int:CDH13 | |
| Interaction | RBM14-RBM4 interactions | 2.72e-04 | 100 | 63 | 4 | int:RBM14-RBM4 | |
| Interaction | NPM1 interactions | HDAC6 SWAP70 SMARCA4 SRP54 LMOD1 CCDC80 SRPK2 MACROH2A2 RBM28 RFC1 SNCA HNRNPU | 2.99e-04 | 1201 | 63 | 12 | int:NPM1 |
| Interaction | DBNL interactions | 3.19e-04 | 190 | 63 | 5 | int:DBNL | |
| Interaction | BICRAL interactions | 3.29e-04 | 43 | 63 | 3 | int:BICRAL | |
| Interaction | FBXW7 interactions | CYBB POLR1A ACLY MYO18A SMARCA4 SRPK2 AKAP13 MACROH2A2 RBM28 RFC1 SNCA YME1L1 | 3.33e-04 | 1215 | 63 | 12 | int:FBXW7 |
| Interaction | EPB41L2 interactions | 3.39e-04 | 299 | 63 | 6 | int:EPB41L2 | |
| Interaction | FRMD4B interactions | 3.41e-04 | 9 | 63 | 2 | int:FRMD4B | |
| Interaction | NAT10 interactions | 3.57e-04 | 302 | 63 | 6 | int:NAT10 | |
| Interaction | CUL1 interactions | CFLAR HDAC6 POLR1A SWAP70 SMARCA4 CCDC168 RBM28 CDC5L RFC1 HNRNPU | 3.61e-04 | 876 | 63 | 10 | int:CUL1 |
| Interaction | ARRB1 interactions | 3.70e-04 | 304 | 63 | 6 | int:ARRB1 | |
| Interaction | CDC42BPB interactions | 3.77e-04 | 109 | 63 | 4 | int:CDC42BPB | |
| Interaction | LAMTOR1 interactions | 3.87e-04 | 722 | 63 | 9 | int:LAMTOR1 | |
| Interaction | RAB35 interactions | 3.98e-04 | 573 | 63 | 8 | int:RAB35 | |
| Interaction | LAMTOR4 interactions | 4.02e-04 | 46 | 63 | 3 | int:LAMTOR4 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.54e-04 | 206 | 45 | 5 | 682 | |
| GeneFamily | AAA ATPases | 3.09e-04 | 53 | 45 | 3 | 413 | |
| GeneFamily | Dyneins, axonemal | 8.04e-04 | 17 | 45 | 2 | 536 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 5.22e-07 | 200 | 63 | 7 | M9463 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 3.73e-07 | 195 | 64 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 3.73e-07 | 195 | 64 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.33e-06 | 159 | 64 | 5 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.33e-06 | 159 | 64 | 5 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-06 | 190 | 64 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 197 | 64 | 5 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 197 | 64 | 5 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 6.29e-05 | 149 | 64 | 4 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | Severe-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.49e-05 | 161 | 64 | 4 | ad3b58e3a8b59a609c8d2d2690d15218d18eabbd | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-05 | 167 | 64 | 4 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 170 | 64 | 4 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 170 | 64 | 4 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 170 | 64 | 4 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.07e-04 | 171 | 64 | 4 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 174 | 64 | 4 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 174 | 64 | 4 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 174 | 64 | 4 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 175 | 64 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 177 | 64 | 4 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 184 | 64 | 4 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 184 | 64 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.42e-04 | 184 | 64 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-04 | 189 | 64 | 4 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 191 | 64 | 4 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.64e-04 | 191 | 64 | 4 | aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Mild/Remission-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.64e-04 | 191 | 64 | 4 | ebb165096de301ba663703d1662d9413ea317867 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 192 | 64 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 192 | 64 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 192 | 64 | 4 | be75783d9578974b662e1cb13bd3442a921fd50a | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.67e-04 | 192 | 64 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Mild/Remission-B_naive-11|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.67e-04 | 192 | 64 | 4 | c6f325cddce43b72f013b21dfffc9987fd68b6a7 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 192 | 64 | 4 | 4fc98f30f8e738816cd93101fbe8ac40889e302a | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.71e-04 | 193 | 64 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 194 | 64 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.81e-04 | 196 | 64 | 4 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.81e-04 | 196 | 64 | 4 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.88e-04 | 198 | 64 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 198 | 64 | 4 | cc162ba4b3b8dec667a8cffd3411965f3f856f8c | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.92e-04 | 199 | 64 | 4 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 1.95e-04 | 200 | 64 | 4 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | 9769185abae084ffac36420c749625e679b70ca8 | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.09e-06 | 191 | 64 | 7 | 7220_DN | |
| Drug | SecinH3 | 1.76e-06 | 9 | 64 | 3 | CID001029232 | |
| Drug | glycylglycylglycine | 4.81e-06 | 40 | 64 | 4 | CID000011161 | |
| Drug | guanine | GBF1 SWAP70 BST1 RRAGA CYTH3 CYTH2 CYTH1 SRP54 AKAP13 RRAGB PLCH1 ARF6 | 6.83e-06 | 902 | 64 | 12 | CID000000764 |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; HL60; HG-U133A | 7.50e-06 | 167 | 64 | 6 | 1607_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 3288_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 4838_UP | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 2085_UP | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 3561_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A | 1.98e-05 | 198 | 64 | 6 | 1924_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 5207_DN | |
| Drug | AC1N9TEG | 2.61e-05 | 124 | 64 | 5 | CID000000478 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.61e-05 | 5 | 64 | 2 | C3281201 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.65e-05 | 195 | 64 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | stromal cell-derived factor 1 alpha measurement | 1.13e-04 | 43 | 64 | 3 | EFO_0008293 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.65e-04 | 9 | 64 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 3.56e-04 | 13 | 64 | 2 | C0265338 | |
| Disease | shigellosis | 5.45e-04 | 16 | 64 | 2 | EFO_0005585 | |
| Disease | central corneal thickness | 5.61e-04 | 309 | 64 | 5 | EFO_0005213 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.14e-03 | 23 | 64 | 2 | C0018784 | |
| Disease | nighttime rest measurement | 1.24e-03 | 24 | 64 | 2 | EFO_0007827 | |
| Disease | pulmonary embolism | 1.35e-03 | 25 | 64 | 2 | EFO_0003827 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 1.46e-03 | 26 | 64 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | biological sex | 1.58e-03 | 230 | 64 | 4 | PATO_0000047 | |
| Disease | treatment-resistant hypertension | 1.73e-03 | 109 | 64 | 3 | EFO_1002006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKMPNKMIRKGVFKD | 906 | Q13523 | |
| RMKHKADAMVEKFGK | 986 | P51826 | |
| GSMKVLEKRLKDMGF | 241 | Q10588 | |
| VMGMIIVFFKSKGKI | 251 | Q6UXE8 | |
| AKMEKKMKILLGGYQ | 711 | Q99459 | |
| RNMFHMSKKTGKFKQ | 896 | Q9H7T0 | |
| ARERGKFKKLMTVMG | 156 | Q8WWZ4 | |
| FAAAMRKMGVKKGDR | 141 | Q86V21 | |
| MMGCFRNQKFRKGKV | 91 | O60911 | |
| KFLVGMKGKDEAMAI | 486 | Q8IX12 | |
| DKFMEKMGVNIVKRK | 16 | P12104 | |
| MSGRSGKKKMSKLSR | 1 | Q9P0M6 | |
| MKSGQMFAKEDLKRK | 2216 | Q12802 | |
| KGRFQGKATKMSRRM | 381 | Q9BTE6 | |
| MKDYMGRGKISKEKS | 116 | O15519 | |
| KLMSFLKLEKGKFGM | 221 | Q76M96 | |
| EAGKALKGMNMKEIK | 166 | Q9NW13 | |
| FKGKQISVQMKGAMA | 916 | Q7Z5J8 | |
| KTLGSKLKKNMGGLM | 511 | Q6GQQ9 | |
| KLKKNMGGLMHSKGS | 516 | Q6GQQ9 | |
| NRRMKYKKDQKGKGM | 241 | O43365 | |
| KEAFEKMKGQMLGSR | 1066 | Q86VF7 | |
| VGDKQSAVKMKMFGK | 591 | Q9BRR8 | |
| GEKMKRAGGNTDMKK | 236 | P29536 | |
| MFNLMKKDKDKDGGR | 1 | Q92614 | |
| TTRVGMKLKEKKMAF | 531 | Q5XG92 | |
| KMMVAGFKKQMADTG | 536 | Q00839 | |
| VAMGRKKFNMDPKKG | 66 | Q15438 | |
| KGKFKTMKMLKLLGN | 836 | Q8N3F8 | |
| KRETKMRGMMAKQEG | 176 | O75330 | |
| MRKYKLKNMTTKGPG | 276 | Q96BT1 | |
| KNEMFVMSGKIKGKT | 146 | Q9UFH2 | |
| AMGRKKFNMDPKKGI | 66 | Q99418 | |
| AMGRKKFNMDPKKGI | 71 | O43739 | |
| QMKKKGFKMEVGQYI | 311 | P04839 | |
| YVGTNMKKLKMRAGG | 206 | Q92538 | |
| QEGKMQEGKGKSSMK | 3706 | Q8NDH2 | |
| KKKGKMKKLGQAMEE | 51 | Q9UBN7 | |
| QKGEKQAMKNYGRKM | 1701 | Q8IVF4 | |
| DMAAKMSKKKKAGGG | 21 | P20648 | |
| KMETQMKGLKAKFRQ | 116 | Q96PB7 | |
| KAKKGMLKGLGDMFR | 1011 | Q8TEW0 | |
| KEKGKGMKNAMNMKD | 96 | Q8N9I0 | |
| MDVFMKGLSKAKEGV | 1 | P37840 | |
| LEKKEGLFRKHMMGK | 421 | O95602 | |
| KFAQMVKKMGGIKGL | 426 | P61011 | |
| KKGKGGAKTLMNTIM | 996 | P51531 | |
| KGAMMSIAFKEGLKI | 781 | P35251 | |
| KKGKGGTKTLMNTIM | 1026 | P51532 | |
| GNVMYKKGKMKEAAQ | 1296 | Q9C0D5 | |
| KMARFTIVDGKMGKG | 291 | Q9UQ90 | |
| LRNKDVKDSMKKMFG | 331 | Q8NGG2 | |
| KFKEAELKMRKQFGM | 136 | Q66K14 | |
| KGKGKRWFAFKMMMA | 136 | Q8TDI8 | |
| NKMKKEGKLIMGIGH | 961 | P53396 | |
| MGKVLSKIFGNKEMR | 1 | P62330 | |
| GGKLIQRKKQKMMEK | 271 | P56962 | |
| MKKKVLLMGKSGSGK | 6 | Q7L523 | |
| MQGKRFVAMKVVKSA | 101 | P78362 | |
| GKMFKDGSMNVSVKL | 1981 | Q709C8 | |
| NTAMKKKVLLMGKSG | 36 | Q5VZM2 | |
| AKGRKKSKMGFQEMV | 926 | Q4KWH8 | |
| KRMVTKFGMSEKLGV | 686 | Q96TA2 | |
| AGVVKKMMKFLKTGG | 561 | Q9H892 | |
| VLKQGYMMKKGHRRK | 211 | Q9UH65 | |
| GKLRGNQYKKMMTKE | 146 | P84157 |